Answers are grounded in this paper and cite their sources.
Background Artificial intelligence (AI)-based computer-aided diagnosis (CADx) systems are increasingly used to classify colorectal polyps during colonoscopy, but their impact depends on how endoscopists interpret AI predictions. This study aimed to evaluate endoscopists’ decision-making after reviewing CADx outputs, using histopathology diagnosis as ground truth. Patients and methods We performed a secondary analysis of a prospective study (NCT06822816) conducted at our centre between 2022 and 2025. All patients and polyps ≤10 mm with documented CADx output and endoscopist diagnosis were included. Endoscopists either accepted CADx classifications (neoplastic vs hyperplastic) or provided alternatives. Our primary outcome was the accuracy of accepted CADx diagnoses; secondary outcomes assessed reclassification patterns after CADx output rejection. Results Our cohort included 754 polyps <10 mm from 367 patients. Accepted CADx diagnoses were correct for 89.1% of neoplastic and 68.7% of hyperplastic CADx predictions. Endoscopists accepted incorrect CADx classifications more frequently when these were neoplastic compared to hyperplastic (64.9% vs 26.5%). Upon rejecting correct CADx neoplastic predictions, endoscopists misclassified 23.4% as sessile serrated lesions (SSLs). Similarly, 29.5% of rejected correct CADx hyperplastic predictions were incorrectly reassigned as SSLs. Conclusions Endoscopists exhibit a diagnostic bias toward neoplasia, particularly misclassifying hyperplastic polyps as SSLs. While this may enhance safety, it may risk unnecessary surveillance colonoscopies and increase costs.
No takes yet. Share an insight, caveat, or question.
Dubois et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: